The effectiveness of eyelid spa in dry eyes and Meibomian gland disease in eye clinic Dararassamee hospital
Article Sidebar
Main Article Content
Abstract
BACKGROUND: Dry eye disease, Meibomian gland dysfunction (MGD), and blepharitis are common ophthalmological conditions frequently encountered in outpatient departments. Patients often present with symptoms such as eye irritation, redness, tearing, excessive eye mucus, or, in severe cases, complications like conjunctivitis, styes, or keratitis. Meibomian gland disease involves the occlusion of sebaceous glands in the eyelids, leading to an unstable lipid layer in the tear film. This instability causes increased tear evaporation, resulting in a condition known as evaporative dry eye. Eyelid care typically includes warm compresses and cleaning the eyelid margin to unblock the Meibomian glands. Gentle compression can help release the occluded meibum, improving gland function.
OBJECTIVE: To evaluate the effectiveness of eyelid spa treatments in reducing symptoms of dry eye disease and blepharitis at the Eye Clinic of Dararassamee Hospital.
METHODS: This retrospective quasi-experimental study included 59 patients diagnosed with dry eye disease and blepharitis who underwent eyelid spa treatments between January 1 and December 31, 2024. Data were collected from two sources: (1) therapy activities from the hospital database to calculate treatment costs and (2) quality-of-life assessments using the Dry Eye-Related Quality-of-Life Score (DEQS-Th) questionnaire. Statistical analysis was performed using the STATA18 program.
RESULTS: The study found that patients received an average of four eyelid spa treatments per case, resulting in statistically significant improvements in quality of life and satisfaction related to eye disease (p<0.001). Most patients' treatment regimens became simpler, requiring fewer medications and significantly reducing treatment costs (p=0.020 and <0.001).
CONCLUSIONS AND RECOMMENDATIONS: Eyelid spa treatments effectively reduce the severity of dry eye disease and Meibomian gland dysfunction, improve patients' quality of life, and decrease treatment costs.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Eberhardt M, Rammohan G. Blepharitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017;124(11S):S20-S6.
Narang P, Donthineni PR, D'Souza S, Basu S. Evaporative dry eye disease due to meibomian gland dysfunction: preferred practice pattern guidelines for diagnosis and treatment. Indian journal of ophthalmology. 2023;71(4):1348–56.
Tansanguan S, Tananuvat N, Wongpakaran N, Wongpakaran T, Ausayakhun S. Thai version of the dry eye-related quality-of-life score questionnaire: preliminary assessment for psychometric properties. BMC Ophthalmol. 2021;21(1):310.
Tananuvat N, Tansanguan S, Wongpakaran N, Wongpakaran T. Reliability, validity, and responsiveness of the Thai version of the dry eye-related quality-of-life score questionnaire. PLoS One. 2022;17(7):e0271228.
Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334-65.
Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea. 2006;25(10):1162-7.
Tawonkasiwattanakun P, Kosaisavee V, Suwannapong N, Tipayuamongholgul M. Symptomatic dry eye prevalence and related factors in an open university, Bangkok, Thailand. Thai journal of public health. 2021;51(3):195-203.
Kudasiewicz-Kardaszewska A, Grant-Kels JM, Grzybowski A. Meibomian gland dysfunction and blepharitis: a common and still unsolved ophthalmic problem. Clin Dermatol. 2023;41(4):491-502.
Riks IA, Trufanov SV, Boutaba R. [Modern approaches to the treatment of meibomian gland dysfunction] Vestn Oftalmol. 2021;137(1):130-6.
